| Orders | Qty | Bid |
|---|---|---|
| 18 | 418490 | 40.41 |
| 229 | 2025472 | 40.4 |
| 188 | 500186 | 40.39 |
| 161 | 500156 | 40.38 |
| 133 | 500128 | 40.37 |
| Ask | Qty | Orders |
|---|---|---|
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
TAKE Solutions Limited is a publicly listed Indian company delivering domain-intensive services and solutions in Life Sciences, Software, and Information Technology. The company specializes in full-service Clinical, Regulatory, and Safety offerings spanning clinical trials, regulatory submissions, and post-marketing safety, backed by industry-specific technology and analytics. Its global clientele includes innovator biopharmaceutical and medical device companies, generics manufacturers, and U.S. federal agencies such as CDC and DoD. The company is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE), with its registered office in Chennai, Tamil Nadu.
TAKE Solutions operates within a single segment, “Life Sciences and Support Services,” reflecting a focused domain concentration. As of March 31, 2025, TAKE Solutions Pte Ltd, Singapore holds 52.90% equity share capital, controlling operational and financial policies. The Group serves clients worldwide, leveraging a team of life sciences experts, process excellence, and bespoke technology to deliver outcomes to pharmaceutical, biotech, and medical device companies.
The company had two subsidiaries as of March 31, 2025. A significant portfolio action was the disinvestment of its material subsidiary, Ecron Acunova Limited, approved in October 2024 and completed by November 2024, allowing strategic focus on core Life Sciences priorities.
The company reports a single operating segment: Life Sciences and Support Services, with global customers in pharmaceuticals, biotech, and medical devices. Geographic operations span across India and global markets, directly and via subsidiaries.
TAKE Solutions engages comprehensively in Life Sciences services, including clinical research, generics development, regulatory affairs, pharmacovigilance, and safety, supported by technology platforms and analytics. It offers full-cycle solutions from clinical trials to post-marketing surveillance, technology-enabled regulatory compliance, and data sciences tailored to client needs globally.

Provides domain-intensive Life Sciences services including clinical research, regulatory submissions, pharmacovigilance, supported by technology and analytics.
Based in Chennai, India, serving a global client base including U.S. federal agencies such as CDC and DoD.
The company had two subsidiaries as of March 31, 2025. TAKE Solutions Pte Ltd, Singapore, owns 52.90% equity and exercises control.